ETC
BIIB icon

Exchange Traded Concepts’s Biogen BIIB Stock Holding History

Exchange Traded Concepts’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Sell
1,770
-53
-3% -$10.1K ﹤0.01% 1182
2026
Q1 		$334K Sell
1,823
-261
-13% -$48.1K ﹤0.01% 1060
2025
Q4 		$367K Sell
2,084
-367
-15% -$60K ﹤0.01% 1051
2025
Q3 		$343K Sell
2,451
-67
-3% -$9.06K ﹤0.01% 1058
2025
Q2 		$316K Buy
2,518
+113
+5% +$14.1K ﹤0.01% 993
2025
Q1 		$329K Buy
2,405
+119
+5% +$17K 0.01% 826
2024
Q4 		$350K Buy
2,286
+624
+38% +$105K 0.01% 832
2024
Q3 		$322K Buy
1,662
+1,626
+4,517% +$340K 0.01% 824
2024
Q2 		$8.35K Sell
36
-254
-88% -$55.2K ﹤0.01% 1106
2024
Q1 		$62.5K Buy
290
+282
+3,525% +$66K ﹤0.01% 950
2023
Q4 		$2.07K Sell
8
-4
-33% -$982 ﹤0.01% 1201
2023
Q3 		$3.08K Buy
12
+4
+50% +$1.07K ﹤0.01% 1234
2023
Q2 		$2.28K Sell
8
-1
-11% -$298 ﹤0.01% 1276
2023
Q1 		$2.5K Sell
9
-10,398
-100% -$2.88M ﹤0.01% 1083
2022
Q4 		$2.88M Buy
10,407
+10,048
+2,799% +$2.84M 0.08% 156
2022
Q3 		$96K Buy
359
+118
+49% +$25.1K ﹤0.01% 754
2022
Q2 		$49K Buy
241
+129
+115% +$26.4K ﹤0.01% 910
2022
Q1 		$24K Sell
112
-22,905
-100% -$4.98M ﹤0.01% 1013
2021
Q4 		$5.52M Buy
23,017
+7,117
+45% +$1.83M 0.11% 122
2021
Q3 		$4.5M Buy
15,900
+15,471
+3,606% +$5.07M 0.11% 113
2021
Q2 		$149K Buy
429
+22
+5% +$6.67K ﹤0.01% 766
2021
Q1 		$114K Sell
407
-35,372
-99% -$9.54M ﹤0.01% 713
2020
Q4 		$8.76M Sell
35,779
-10,767
-23% -$2.78M 0.41% 37
2020
Q3 		$13.2M Buy
46,546
+11,419
+33% +$3.18M 0.75% 22
2020
Q2 		$9.4M Buy
35,127
+30,295
+627% +$9.11M 1.56% 5
2020
Q1 		$1.53M Buy
4,832
+4,755
+6,175% +$1.44M 0.83% 31
2019
Q4 		$23K Buy
+77
New +$21.4K ﹤0.01% 289

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exchange Traded Concepts's BIIB Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Biogen (BIIB) stake by 2.9% in Q2 2026, selling an estimated $10.1K and leaving 1,770 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Exchange Traded Concepts first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. The position peaked at $13.2M in Q3 2020. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Exchange Traded Concepts held 1,770 shares of Biogen worth $382K as of Q2 2026.
  • Exchange Traded Concepts sold 53 Biogen shares in Q2 2026, an estimated $10.1K.
  • Biogen made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1182 holding.
  • Exchange Traded Concepts first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Biogen position peaked at $13.2M in Q3 2020.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.